Respiratory syncytial virus infection and immunity

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Reviews in Medical Virology

• Publication date

  2012-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/rmv.1704PMID 22290692
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• This information is current as Respiratory Syncytial Virus Infection Immunomodulatory IL-10 During T Cell Subsets Produce + Multiple CD 4

  2011cited by this paper
• Respiratory Syncytial Virus Infection in Adults

  2011cited by this paper
• RSV-induced bronchial epithelial cell PD-L1 expression inhibits CD8+ T cell nonspecific antiviral activity.

  2011cited by this paper
• Respiratory Syncytial Virus Interferon Antagonist NS1 Protein Suppresses and Skews the Human T Lymphocyte Response

  2011cited by this paper
• Primary Human mDC1, mDC2, and pDC Dendritic Cells Are Differentially Infected and Activated by Respiratory Syncytial Virus

  2011cited by this paper
• Regulation of STAT signaling in mouse bone marrow derived dendritic cells by respiratory syncytial virus.

  2011cited by this paper
• Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV.

  2011cited by this paper
• Modulation of the dendritic cell-T-cell synapse to promote pathogen immunity and prevent autoimmunity.

  2011cited by this paper
• IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease.

  2011cited by this paper
• Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

  2010cited by this paper
• Epitope-Specific Regulatory CD4 T Cells Reduce Virus-Induced Illness while Preserving CD8 T-Cell Effector Function at the Site of Infection

  2010cited by this paper
• Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

  2010cited by this paper
• Respiratory syncytial virus market

  2010cited by this paper
• Foxp3+ CD4 Regulatory T Cells Limit Pulmonary Immunopathology by Modulating the CD8 T Cell Response during Respiratory Syncytial Virus Infection

  2010cited by this paper
• Effects of Human Respiratory Syncytial Virus, Metapneumovirus, Parainfluenza Virus 3 and Influenza Virus on CD4+ T Cell Activation by Dendritic Cells

  2010cited by this paper
• This information is current as Infectionsduring Respiratory Syncytial Virus T Cell Balance + / CD 8 + Virus-Specific CD 4 Serum Antibodies Critically Affect Bleek

  2010influential reference
• A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

  2010cited by this paper
• Efficient Lung Recruitment of Respiratory Syncytial Virus-Specific Th1 Cells Induced by Recombinant Bacillus Calmette-Guérin Promotes Virus Clearance and Protects from Infection

  2010cited by this paper
• Transforming Growth Factor Beta Is a Major Regulator of Human Neonatal Immune Responses following Respiratory Syncytial Virus Infection

  2010influential reference
• CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC

  2010cited by this paper
• Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children.

  2010cited by this paper
• CD25+ Natural Regulatory T Cells Are Critical in Limiting Innate and Adaptive Immunity and Resolving Disease following Respiratory Syncytial Virus Infection

  2010cited by this paper
• Use of genetically modified bacteria to modulate adaptive immunity.

  2009cited by this paper
• Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice.

  2009cited by this paper
• Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3.

  2009cited by this paper
• Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis.

  2009cited by this paper
• Respiratory Syncytial Virus-Induced Activation and Migration of Respiratory Dendritic Cells and Subsequent Antigen Presentation in the Lung-Draining Lymph Node

  2009cited by this paper
• T-cell antagonism by short half-life pMHC ligands can be mediated by an efficient trapping of T-cell polarization toward the APC

  2009cited by this paper
• Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice.

  2009cited by this paper
• Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

  2009cited by this paper
• Subversion of Pulmonary Dendritic Cell Function by Paramyxovirus Infections1

  2009cited by this paper
• Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.

  2009cited by this paper
• Regulatory T Cells Promote Early Influx of CD8+ T Cells in the Lungs of Respiratory Syncytial Virus-Infected Mice and Diminish Immunodominance Disparities

  2009cited by this paper
• STAT1 Negatively Regulates Lung Basophil IL-4 Expression Induced by Respiratory Syncytial Virus Infection1

  2009influential reference
• Comparison of cytokine responses in nasopharyngeal aspirates from children with viral lower respiratory tract infections

  2009cited by this paper
• IL-9 Regulates Pathology during Primary and Memory Responses to Respiratory Syncytial Virus Infection1

  2009cited by this paper
• Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients

  2009cited by this paper
• Impairment of the CD8+ T cell response in lungs following infection with human respiratory syncytial virus is specific to the anatomical site rather than the virus, antigen, or route of infection

  2008cited by this paper
• Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells

  2008cited by this paper
• Host immunity during RSV pathogenesis.

  2008cited by this paper
• T Helper Lymphocyte Response to Respiratory Syncytial Virus and Its Components in Patients with Respiratory Allergy and Nonatopic Controls

  2008cited by this paper
• The Balance between Plasmacytoid DC versus Conventional DC Determines Pulmonary Immunity to Virus Infections

  2008cited by this paper
• Respiratory syncytial virus infection in adults

  2008cited by this paper
• Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG

  2008cited by this paper
• Protective effect of a RSV subunit vaccine candidate G1F/M2 was enhanced by a HSP70-Like protein in mice.

  2008cited by this paper
• T‐cell activation through immunological synapses and kinapses

  2008cited by this paper
• Inhibition of CD8+ T Lymphocytes Attenuates Respiratory Syncytial Virus-Enhanced Allergic Inflammation

  2008cited by this paper
• The Number of Respiratory Syncytial Virus (RSV)-Specific Memory CD8 T Cells in the Lung Is Critical for Their Ability to Inhibit RSV Vaccine-Enhanced Pulmonary Eosinophilia1

  2008cited by this paper
• RNA Interference Inhibits Respiratory Syncytial Virus Replication and Disease Pathogenesis without Inhibiting Priming of the Memory Immune Response

  2008cited by this paper
• Nonstructural Proteins 1 and 2 of Respiratory Syncytial Virus Suppress Maturation of Human Dendritic Cells

  2008cited by this paper
• The Secreted Form of Respiratory Syncytial Virus G Glycoprotein Helps the Virus Evade Antibody-Mediated Restriction of Replication by Acting as an Antigen Decoy and through Effects on Fc Receptor-Bearing Leukocytes

  2008cited by this paper
• Sustained desensitization to bacterial Toll-like receptor ligands after resolutionof respiratory influenza infection

  2008cited by this paper
• The capacity of Salmonella to survive inside dendritic cells and prevent antigen presentation to T cells is host specific

  2008cited by this paper
• Pulmonary eosinophilia requires interleukin‐5, eotaxin‐1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein

  2008cited by this paper
• The Role of T Cells in the Enhancement of Respiratory Syncytial Virus Infection Severity during Adult Reinfection of Neonatally Sensitized Mice

  2008cited by this paper
• Increased pathogenesis and inflammation of airways from respiratory syncytial virus infection in T cell deficient nude mice

  2008cited by this paper
• IL-13 Is Required for Eosinophil Entry into the Lung during Respiratory Syncytial Virus Vaccine-Enhanced Disease1

  2008cited by this paper
• Respiratory syncytial virus infection provokes airway remodelling in allergen‐exposed mice in absence of prior allergen sensitization

  2008cited by this paper
• Predominance of Th2 cytokines, CXC chemokines and innate immunity mediators at the mucosal level during severe respiratory syncytial virus infection in children.

  2007cited by this paper
• Modulation of immunological synapse by membrane-bound and soluble ligands.

  2007cited by this paper
• Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.

  2007cited by this paper
• Recombinant Sendai virus induces T cell immunity against respiratory syncytial virus that is protective in the absence of antibodies.

  2007cited by this paper
• Oral Respiratory Syncytial Virus (RSV) DNA Vaccine Expressing RSV F Protein Delivered by AttenuatedSalmonella typhimurium

  2007cited by this paper
• T Helper 1 Background Protects Against Airway Hyperresponsiveness and Inflammation in Guinea Pigs With Persistent Respiratory Syncytial Virus Infection

  2007cited by this paper
• Immune complex-induced enhancement of bacterial antigen presentation requires Fcγ Receptor III expression on dendritic cells

  2007cited by this paper
• Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus

  2007cited by this paper
• Respiratory Syncytial Virus NS1 Protein Degrades STAT2 by Using the Elongin-Cullin E3 Ligase

  2007cited by this paper
• Respiratory syncytial virus differentially activates murine myeloid and plasmacytoid dendritic cells

  2007cited by this paper
• Respiratory Syncytial Virus Synergizes with Th2 Cytokines to Induce Optimal Levels of TARC/CCL171

  2007cited by this paper
• Alpha and Lambda Interferon Together Mediate Suppression of CD4 T Cells Induced by Respiratory Syncytial Virus

  2006cited by this paper
• Regulated expression of FcgammaR in human dendritic cells controls cross-presentation of antigen-antibody complexes.

  2006cited by this paper
• Extrapulmonary manifestations of severe respiratory syncytial virus infection – a systematic review

  2006cited by this paper
• Synergistically Upregulated Interleukin-10 Production in Cocultures of Monocytes and T Cells after Stimulation with Respiratory Syncytial Virus

  2006cited by this paper
• Functional impairment of cytotoxic T cells in the lung airways following respiratory virus infections

  2006influential reference
• A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines

  2006influential reference
• Respiratory Syncytial Virus G Protein and G Protein CX3C Motif Adversely Affect CX3CR1+ T Cell Responses

  2006cited by this paper
• Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus.

  2006cited by this paper
• Local CD11c+ MHC Class II− Precursors Generate Lung Dendritic Cells during Respiratory Viral Infection, but Are Depleted in the Process1

  2006cited by this paper
• Mismanagement as a prelude to privatisation of the UK NHS.

  2006cited by this paper
• Plasmacytoid Dendritic Cells Limit Viral Replication, Pulmonary Inflammation, and Airway Hyperresponsiveness in Respiratory Syncytial Virus Infection1

  2006cited by this paper
• Extrapulmonary manifestations of severe RSV bronchiolitis.

  2006cited by this paper
• Think outside the box: extrapulmonary manifestations of severe respiratory syncytial virus infection

  2006cited by this paper
• Dendritic cells: translating innate to adaptive immunity.

  2006cited by this paper
• Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus

  2006cited by this paper
• Intranasal immunisation with inactivated RSV and bacterial adjuvants induces mucosal protection and abrogates eosinophilia upon challenge

  2006cited by this paper
• Antiviral signaling through pattern recognition receptors.

  2006cited by this paper
• Regulated Expression of FcγR in Human Dendritic Cells Controls Cross-Presentation of Antigen-Antibody Complexes1

  2006cited by this paper
• Virulent Salmonella enterica Serovar Typhimurium Evades Adaptive Immunity by Preventing Dendritic Cells from Activating T Cells

  2006cited by this paper
• New generation live vaccines against human respiratory syncytial virus designed by reverse genetics.

  2005cited by this paper
• Respiratory Syncytial Virus Infection of Monocyte-Derived Dendritic Cells Decreases Their Capacity to Activate CD4 T Cells

  2005cited by this paper
• Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections.

  2005cited by this paper
• Effects of Nonstructural Proteins NS1 and NS2 of Human Respiratory Syncytial Virus on Interferon Regulatory Factor 3, NF-κB, and Proinflammatory Cytokines

  2005cited by this paper
• Inhibition of respiratory viruses by nasally administered siRNA

  2005cited by this paper
• Improved Effector Activity and Memory CD8 T Cell Development by IL-2 Expression during Experimental Respiratory Syncytial Virus Infection 1

  2004cited by this paper
• Salmonella Escape from Antigen Presentation Can Be Overcome by Targeting Bacteria to Fcγ Receptors on Dendritic Cells1

  2004cited by this paper
• Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children.

  2004influential reference
• Respiratory viral infections in patients with chronic, obstructive pulmonary disease

  2004cited by this paper
• Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells.

  2004cited by this paper
• Recombinant Respiratory Syncytial Viruses Lacking the C-Terminal Third of the Attachment (G) Protein Are Immunogenic and Attenuated In Vivo and In Vitro

  2004cited by this paper
• A role for the immunological synapse in lineage commitment of CD4 lymphocytes

  2004cited by this paper

• Development of a HEp2‐CDX Mouse Model With Sustained High RSV Viral Loads for Robust Antiviral Therapeutic Evaluation

  2025cites this paper
• Comparison of Omicron and respiratory virus infections in pediatric liver transplantation: Impact of perioperative identification status

  2025cites this paper
• A bivalent mRNA vaccine against RSV infection in rodent models

  2025cites this paper
• Post-pandemic trends: Epidemiological and etiological insights into acute respiratory infections in southern China.

  2024cites this paper
• Differential expression of cytokines and elevated levels of MALAT1 - Long non-coding RNA in response to non-structural proteins of human respiratory syncytial virus.

  2024cites this paper
• Self-amplifying mRNA vaccines protect elderly BALB/c mice against a lethal respiratory syncytial virus infection.

  2024cites this paper
• Landscape of respiratory syncytial virus

  2024cites this paper
• Recent advances in natural products and derivatives with antiviral activity against respiratory syncytial virus (RSV)

  2024cites this paper
• Respiratory syncytial virus: A new era

  2024cites this paper
• CELL-PENETRATING PEPTIDES NANO-CONJUGATED WITH METALLIC NANOPARTICLE FOR THE DEVELOPMENT OF THERAPEUTIC AND OR PROPHYLACTIC AGENTS AGAINST RESPIRATORY SYNCYTIAL VIRUS

  2023cites this paper
• Role of the cAMP-PKA-NF-κB pathway in Mucin1 over-expression in A549 cells during Respiratory syncytial virus infection

  2023cites this paper
• New Developments and Challenges in Antibody-Based Therapies for the Respiratory Syncytial Virus

  2023cites this paper
• A Fragile Balance: Does Neutrophil Extracellular Trap Formation Drive Pulmonary Disease Progression?

  2021cites this paper
• Designing of Potential Polyvalent Vaccine Model for Respiratory Syncytial Virus by System Level Immunoinformatics Approaches

  2021cites this paper
• Epidemiology and genetic characterization of respiratory syncytial virus in children with acute respiratory infections: Findings from the influenza sentinel surveillance network in Central African Republic, 2015 to 2018

  2021cites this paper
• Revisiting respiratory syncytial virus’s interaction with host immunity, towards novel therapeutics

  2020cites this paper
• Respiratory Syncytial Virus's Non-structural Proteins: Masters of Interference

  2020cites this paper
• Epidemiology and phylogenetic analysis of respiratory viruses from 2012 to 2015 – A sentinel surveillance report from union territory of Puducherry, India

  2020cites this paper
• Immune-Modulation by the Human Respiratory Syncytial Virus: Focus on Dendritic Cells

  2019cites this paper
• Antiviral activity of ethanol extract of Lophatherum gracile against respiratory syncytial virus infection.

  2019cites this paper
• A novel RSV F‐Fc fusion protein vaccine reduces lung injury induced by respiratory syncytial virus infection

  2019cites this paper
• Host Components Contributing to Respiratory Syncytial Virus Pathogenesis

  2019cites this paper
• Hurdles in Vaccine Development against Respiratory Syncytial Virus

  2019cites this paper
• Safety and immunogenicity of a respiratory syncytial virus fusion glycoprotein F subunit vaccine in healthy adults: Results of a phase 1, randomized, observer-blind, controlled, dosage-escalation study.

  2019cites this paper
• Notch Ligand Delta-like 4 (Dll4) Induces Epigenetic Mechanism in Regulatory T Cell FunctionDuring Pulmonary Viral Infection

  2018cites this paper
• CD38 modulates respiratory syncytial virus‐driven proinflammatory processes in human monocyte‐derived dendritic cells

  2018cites this paper
• Host-pathogens interactions during RSV / S. pneumoniae infection immune response and p53 pathway

  2017cites this paper
• Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases

  2017cites this paper
• Natural helper cells mediate respiratory syncytial virus-induced airway inflammation by producing type 2 cytokines in an IL-33-dependent manner.

  2017cites this paper
• Immune and inflammatory response in bronchiolitis due to respiratory Syncytial Virus and Rhinovirus infections in infants.

  2017cites this paper
• Respiratory syncytial virus: an overview of infection biology and vaccination strategies

  2017cites this paper
• Impact of Climatic Variability in the Respiratory Syncytial Virus Pattern in Children Under 5 Years-Old Using the Bulto Climatic Index in Cuba

  2017cites this paper
• Prevailing genotype distribution and characteristics of human respiratory syncytial virus in northeastern China

  2016cites this paper
• Neutrophil Extracellular Traps in Pulmonary Diseases: Too Much of a Good Thing?

  2016cites this paper
• Evolution and Transmission of Respiratory Syncytial Group A (RSV-A) Viruses in Guangdong, China 2008–2015

  2016influential citation
• Relevant Cytokines in the Management of Community-Acquired Pneumonia

  2016cites this paper
• Suppression of IRG-1 Reduces Inflammatory Cell Infiltration and Lung Injury in Respiratory Syncytial Virus Infection by Reducing Production of Reactive Oxygen Species

  2016cites this paper
• Mathematical models for respiratory syncytial virus (RSV) transmission

  2016cites this paper
• IL‐33 Receptor (ST2) Signalling is Important for Regulation of Th2‐Mediated Airway Inflammation in a Murine Model of Acute Respiratory Syncytial Virus Infection

  2015cites this paper
• N-((1,3-Diphenyl-1H-pyrazol-4-yl)methyl)anilines: A novel class of anti-RSV agents.

  2015cites this paper
• Introduction to Virology

  2015cites this paper
• The role of Th17 and Treg responses in the pathogenesis of RSV infection

  2015cites this paper
• Immunological, Viral, Environmental, and Individual Factors Modulating Lung Immune Response to Respiratory Syncytial Virus

  2015cites this paper
• New insights on the viral and host factors contributing to the airway pathogenesis caused by the respiratory syncytial virus

  2015cites this paper
• Atomic force microscopic investigation of respiratory syncytial virus infection in HEp‐2 cells

  2014cites this paper
• Interferon lambda 1–3 expression in infants hospitalized for RSV or HRV associated bronchiolitis

  2014cites this paper
• Central nervous system alterations caused by infection with the human respiratory syncytial virus

  2014cites this paper
• © 201 stem alterations caused e human respiratory syncytial virus

  2014cites this paper
• Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design

  2014cites this paper
• Loop mediated isothermal amplification to detect respiratory syncytial virus in respiratory specimens

  2014cites this paper
• European survey on laboratory preparedness, response and diagnostic capacity for Crimean-Congo haemorrhagic fever, 2012.

  2014cites this paper
• Respiratory Syncytial Virus Can Infect Basal Cells and Alter Human Airway Epithelial Differentiation

  2014influential citation
• Rapid spread of the novel respiratory syncytial virus A ON1 genotype, central Italy, 2011 to 2013.

  2014influential citation
• Live Attenuated B. pertussis BPZE1 Rescues the Immune Functions of Respiratory Syncytial Virus Infected Human Dendritic Cells by Promoting Th1/Th17 Responses

  2014cites this paper
• Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity

  2014cites this paper
• Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response.

  2013cites this paper
• Respiratory syncytial virus protects against the subsequent development of ovalbumin‐induced allergic responses by inhibiting Th2‐type γδ T cells

  2013cites this paper
• Modelling the transmission dynamics of RSV and the impact of routine vaccination

  2013cites this paper
• Wish list for viral vaccinologists

  2012cites this paper